79 related articles for article (PubMed ID: 22275079)
1. Insights into internal dynamics of 6-phosphogluconolactonase from Trypanosoma brucei studied by nuclear magnetic resonance and molecular dynamics.
Calligari PA; Salgado GF; Pelupessy P; Lopes P; Ouazzani J; Bodenhausen G; Abergel D
Proteins; 2012 Apr; 80(4):1196-210. PubMed ID: 22275079
[TBL] [Abstract][Full Text] [Related]
2. Insights into the enzymatic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei using structural data and molecular dynamics simulation.
Duclert-Savatier N; Poggi L; Miclet E; Lopes P; Ouazzani J; Chevalier N; Nilges M; Delarue M; Stoven V
J Mol Biol; 2009 May; 388(5):1009-21. PubMed ID: 19345229
[TBL] [Abstract][Full Text] [Related]
3. Three dimensional structure and implications for the catalytic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei.
Delarue M; Duclert-Savatier N; Miclet E; Haouz A; Giganti D; Ouazzani J; Lopez P; Nilges M; Stoven V
J Mol Biol; 2007 Feb; 366(3):868-81. PubMed ID: 17196981
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of CYP51: implications for function and inhibitor design.
Yu X; Cojocaru V; Mustafa G; Salo-Ahen OM; Lepesheva GI; Wade RC
J Mol Recognit; 2015 Feb; 28(2):59-73. PubMed ID: 25601796
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of SUMO from Trypanosoma brucei and its interaction with Ubc9.
Shang Q; Xu C; Zhang J; Zhang X; Tu X
Proteins; 2009 Jul; 76(1):266-9. PubMed ID: 19343802
[No Abstract] [Full Text] [Related]
6. Solution structure of Urm1 from Trypanosoma brucei.
Zhang W; Zhang J; Xu C; Wang T; Zhang X; Tu X
Proteins; 2009 May; 75(3):781-5. PubMed ID: 19241476
[No Abstract] [Full Text] [Related]
7. Backbone H(N), N, C(alpha), C', and C(beta) assignment of the 6-phosphogluconolactonase, a 266-residue enzyme of the pentose-phosphate pathway from human parasite Trypanosoma brucei.
Miclet E; Duffieux F; Lallemand JY; Stoven V
J Biomol NMR; 2003 Mar; 25(3):249-50. PubMed ID: 12652137
[No Abstract] [Full Text] [Related]
8. 1H, 13C and 15N resonance assignments for a putative ADF/Cofilin from Trypanosoma brucei.
Dai K; Yuan G; Liao S; Zhang J; Tu X
Biomol NMR Assign; 2011 Oct; 5(2):249-51. PubMed ID: 21523437
[TBL] [Abstract][Full Text] [Related]
9. The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sickness.
Friedman AJ; Durrant JD; Pierce LC; McCorvie TJ; Timson DJ; McCammon JA
Chem Biol Drug Des; 2012 Aug; 80(2):173-81. PubMed ID: 22487100
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ligand binding and protein dynamics of human retinoid X receptor alpha ligand-binding domain by nuclear magnetic resonance.
Lu J; Cistola DP; Li E
Biochemistry; 2006 Feb; 45(6):1629-39. PubMed ID: 16460010
[TBL] [Abstract][Full Text] [Related]
11. 1H, 13C and 15N resonance assignment of truncated SUMO from Trypanosoma brucei.
Shang Q; Lin L; Zhang J; Tu X
Biomol NMR Assign; 2007 Jul; 1(1):103-4. PubMed ID: 19636839
[TBL] [Abstract][Full Text] [Related]
12. Determination of dihedral Psi angles in large proteins by combining NH(N)/C(alpha)H(alpha) dipole/dipole cross-correlation and chemical shifts.
Loth K; Abergel D; Pelupessy P; Delarue M; Lopes P; Ouazzani J; Duclert-Savatier N; Nilges M; Bodenhausen G; Stoven V
Proteins; 2006 Sep; 64(4):931-9. PubMed ID: 16786593
[TBL] [Abstract][Full Text] [Related]
13. Simulations of apo and holo-fatty acid binding protein: structure and dynamics of protein, ligand and internal water.
Bakowies D; van Gunsteren WF
J Mol Biol; 2002 Jan; 315(4):713-36. PubMed ID: 11812142
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition.
Ferreira LG; Andricopulo AD
Future Med Chem; 2013 Oct; 5(15):1753-62. PubMed ID: 24144411
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Montin K; Cervellati C; Dallocchio F; Hanau S
FEBS J; 2007 Dec; 274(24):6426-35. PubMed ID: 18021252
[TBL] [Abstract][Full Text] [Related]
16. Structural role of the active-site metal in the conformation of Trypanosoma brucei phosphoglycerate mutase.
Mercaldi GF; Pereira HM; Cordeiro AT; Michels PA; Thiemann OH
FEBS J; 2012 Jun; 279(11):2012-21. PubMed ID: 22458781
[TBL] [Abstract][Full Text] [Related]
17. Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei.
Amaro RE; Swift RV; McCammon JA
PLoS Negl Trop Dis; 2007 Nov; 1(2):e68. PubMed ID: 18060084
[TBL] [Abstract][Full Text] [Related]
18. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
[TBL] [Abstract][Full Text] [Related]
19. 1H, 13C, and 15N assignment of the oxidized and reduced forms of T. brucei glutathione peroxidase-type tryparedoxin peroxidase.
Melchers J; Krauth-Siegel L; Muhle-Goll C
Biomol NMR Assign; 2008 Jun; 2(1):65-8. PubMed ID: 19636927
[TBL] [Abstract][Full Text] [Related]
20. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
